Related Experiment Video
Updated: Jun 16, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Sphingolipid metabolism and hematologic disorders: current understanding and future directions
Zheshu Kuang1, Tianjun Huang2, Guanjun Chen2
1Chenzhou Third People's Hospital (Group), Chenzhou, Hunan, China.
Frontiers in Physiology
|June 15, 2026
Summary
Sphingolipid metabolism is crucial for cell function and its abnormalities are linked to hematological disorders. Understanding these links offers new diagnostic and therapeutic strategies for blood diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Sphingolipids are vital structural and signaling molecules, essential for cellular homeostasis.
- Metabolomic advancements reveal sphingolipid metabolic dysregulation in various hematological disorders, including malignancies and immune conditions.
Purpose of the Study:
- To systematically review sphingolipid metabolism's role in hematological diseases.
- To focus on metabolic reprogramming, signaling pathways, and potential therapeutic targets.
Main Methods:
- Systematic literature review integrating clinical and basic research.
- Analysis of sphingolipid metabolic pathways and associated regulatory mechanisms.
Main Results:
- Sphingolipid metabolic abnormalities are implicated in immune thrombocytopenia, myeloproliferative neoplasms, graft-versus-host disease, hereditary blood disorders, and hematologic malignancies.
- Identification of potential biomarkers and therapeutic targets within sphingolipid metabolism.
Conclusions:
- Sphingolipid metabolism reprogramming is a key factor in hematological disease pathogenesis.
- Further research into sphingolipid pathways may yield novel diagnostic and therapeutic strategies for hematological diseases.
Related Concept Videos
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:20Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...